Search Results
Jun 01, 2026, 15:26 ET Are CZR, AVNS, GBTG Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-czr-avns-gbtg-obtaining-fair-deals-for-their-shareholders-302787462.htmlSOURCE
More news about: Halper Sadeh LLP
Jun 01, 2026, 14:57 ET $HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger--AFBI, QXO, BLD, and AVNS
AVNS) related to its sale to affiliates of American Industrial Partners. Under the terms of the proposed transaction, Avanos shareholders will receive
More news about: Monteverde & Associates PC
May 05, 2026, 07:00 ET Avanos Medical, Inc. Announces First Quarter 2026 Results
$1.272 billionALPHARETTA, Ga., May 5, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2026 financial results.
More news about: Avanos Medical
Apr 23, 2026, 11:43 ET Are WSR, SLNO, OMEX, AVNS Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-wsr-slno-omex-avns-obtaining-fair-deals-for-their-shareholders-302751928.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 22, 2026, 13:27 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--LEG, AVNS, GRTX, and GSAT
AVNS) related to its sale to affiliates of American Industrial Partners. Under the terms of the proposed transaction, Avanos shareholders will receive
More news about: Monteverde & Associates PC
Apr 21, 2026, 15:12 ET Are LEG, AVNS, MKC Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-leg-avns-mkc-obtaining-fair-deals-for-their-shareholders-302749188.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 14, 2026, 10:58 ET Are AVNS, LEG, ASRT Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-avns-leg-asrt-obtaining-fair-deals-for-their-shareholders-302741748.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 14, 2026, 10:20 ET Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, April 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial.
More news about: Ademi LLP
Apr 14, 2026, 06:00 ET Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
ALPHARETTA, Ga. and NEW YORK, April 14, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial
More news about: Avanos Medical
Mar 17, 2026, 08:45 ET SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Avanos Medical, Inc. (NYSE: AVNS)
March 17, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Avanos Medical, Inc. (NYSE: AVNS) on behalf of the company's shareholders. The investigation seeks to determine whether Avanos Medical's directors breached their fiduciary duties in
More news about: Purcell & Lefkowitz LLP
Mar 02, 2026, 17:28 ET Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer, will participate in
More news about: Avanos Medical
Feb 26, 2026, 07:00 ET Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
RadoffALPHARETTA, Ga., Feb. 26, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced that it intends to nominate James ("Jim") L. Cunniff, President and CEO of Electromed, Inc.,
More news about: Avanos Medical
Feb 24, 2026, 07:00 ET Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
2026ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2025 results.
More news about: Avanos Medical
Feb 16, 2026, 16:30 ET Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues., Feb. 24 at
More news about: Avanos Medical
Feb 03, 2026, 08:00 ET CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
ALPHARETTA, Ga., Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospital Outpatient Prospective Payment System
More news about: Avanos Medical
Jan 20, 2026, 08:00 ET Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pain care through an integrated
More news about: Avanos Medical
Jan 07, 2026, 20:25 ET Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco,
More news about: Avanos Medical
Nov 05, 2025, 07:00 ET Avanos Medical, Inc. Announces Third Quarter 2025 Results
ALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2025 financial results.
More news about: Avanos Medical
Nov 04, 2025, 06:30 ET Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 - Exclusive Report by MarketsandMarkets™
players The report profiles key companies, including Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), and WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain),
More news about: MarketsandMarkets
Oct 27, 2025, 10:31 ET Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed., Nov. 5, at 9 a.m. ET. The
More news about: Avanos Medical
Oct 23, 2025, 08:00 ET WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business
privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avanos Medical, Inc. (NYSE: AVNS) to acquire substantially all assets and rights related to Avanos' US Game Ready® orthopedic rental business.
More news about: WRS Group
Sep 15, 2025, 07:00 ET Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in
More news about: Avanos Medical
Aug 05, 2025, 06:45 ET Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president,
More news about: Avanos Medical
Aug 05, 2025, 06:30 ET Avanos Medical, Inc. Announces Second Quarter 2025 Results
ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results.
More news about: Avanos Medical
Jul 31, 2025, 16:15 ET Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in
More news about: Avanos Medical